We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Cardiology

Journal Scan / Research · February 15, 2021

High-Risk Patients and Sacubitril/Valsartan in PIONEER-HF

Circulation: Heart Failure


Additional Info

Circulation: Heart Failure
Efficacy and Safety of Sacubitril/Valsartan in High-Risk Patients in the PIONEER-HF Trial
Circ Heart Fail 2021 Feb 03;[EPub Ahead of Print], DD Berg, MD Samsky, EJ Velazquez, CI Duffy, Y Gurmu, E Braunwald, DA Morrow, AD DeVore

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading